• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

BTI cuts red ink as sales boom

Article

Biomagnetic Technologies of San Diego reported a sharp increase in sales and a lower net loss for fiscal 1997 (end-September) as the company began recognizing revenue from magnetic source imaging systems that had been delayed from shipping in 1996. BTI

Biomagnetic Technologies of San Diego reported a sharp increase in sales and a lower net loss for fiscal 1997 (end-September) as the company began recognizing revenue from magnetic source imaging systems that had been delayed from shipping in 1996. BTI also reported that a European customer is developing a new version of its Magnes technology for applications other than the brain.

For the year, BTI posted revenues of $11 million, compared with $1.4 million in fiscal 1996, while the company's net loss shrank to $3 million, compared with $14.8 million the year before. BTI's revenues for the year included sales from the company's first Magnes 1300C system, which is being developed at the European site.

Recent Videos
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Detecting PCa Recurrence in African Americans: Can 18F-Flotufolastat Have an Impact?
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Related Content
© 2024 MJH Life Sciences

All rights reserved.